Efficacy of Pre-S-containing HBV vaccine combined with lamivudine in the treatment of chronic HBV infection

Digestive Diseases and Sciences

Volumn 54, Issue 9, 2009, Pages 2026-2030

  Senturk, Hakan ^a   Tabak, Fehmi ^a   Ozaras, Resat ^a   Erdem, Levent ^b   Canbakan, Billur ^a   Mert, Ali ^a   Yurdakul, Ibrahim ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Hepatitis B; Lamivudine; Therapeutic vaccination

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE; HEPATITIS B SURFACE ANTIGEN; PRESURFACE PROTEIN 2, HEPATITIS B SURFACE ANTIGEN; PROTEIN PRECURSOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA VIRUS; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; HEPATITIS B; HUMAN; MALE; PRIORITY JOURNAL; RELAPSE; SEROCONVERSION; TREATMENT RESPONSE; VACCINATION; CLINICAL TRIAL; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PILOT STUDY;

ADOLESCENT; ADULT; COMBINED MODALITY THERAPY; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; PILOT PROJECTS; PROTEIN PRECURSORS; REVERSE TRANSCRIPTASE INHIBITORS; YOUNG ADULT;

EID: 68249151151     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0586-2     Document Type: Article

References (16)

1. N Leung 2002 Treatment of chronic hepatitis B: case selection and duration of therapy J Gastroenterol Hepatol 17 409 414 10.1046/j.1440-1746.2002. 02767.x (Pubitemid 34537291)
2. NC Tassopoulos R Volpes G Pastore 1999 Efficacy of lamivudine in patients with hepatitis B e antigen negative/hepatitis B virus DNA positive (precore mutant) chronic hepatitis B Hepatology 29 889 896 10.1002/hep.510290321
3. SK Fung F Wong M Hussain AS Lok 2004 Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis B J Viral Hepat 11 432 438 10.1111/j.1365-2893.2004.00556.x (Pubitemid 39336224)
4. YF Liaw 2003 Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy J Gastroenterol Hepatol 18 246 252 10.1046/j.1440-1746.2003.02976.x (Pubitemid 36513152)
5. H Senturk F Tabak M Akdogan 2002 Therapeutic vaccination in chronic hepatitis B J Gastroenterol Hepatol 17 72 76 10.1046/j.1440-1746.2002.02652.x (Pubitemid 34304390)
6. JL Dienstag RP Perrillo ER Schiff M Bartholomew C Vicary M Rubin 1995 A preliminary trial of lamivudine for chronic hepatitis B infection N Engl J Med 333 1657 1661 10.1056/NEJM199512213332501 (Pubitemid 26001954)
7. K Borroto-Esoda S Arteburn A Snow 2006 Pawlotsky: final analysis of virological outcomes and resistance during 5 years of adefovir dipivoxil monotherapy in HBeAg-negative patients J Hepatol 44 Suppl S179 S180 10.1016/S0168-8278(06)80483-6
8. M Sherman C Yurdaydin J Sollano 2006 Entecavir for the treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B Gastroenterology 130 2039 2049 10.1053/j.gastro.2006.04.007 (Pubitemid 43816960)
9. SM Akbar K Kajino K Tanimoto 1997 Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice J Hepatol 26 131 137 10.1016/S0168-8278(97)80019-0 (Pubitemid 27072614)
10. GJ Webster S Reignat D Brown 2004 Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy J Virol 78 5707 5719 10.1128/JVI.78.11.5707-5719.2004 (Pubitemid 38661658)
11. A Thermet T Buronfosse B Werle-Lapostolle 2008 DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection J Gen Virol 89 1192 1201 10.1099/vir.0.83583-0
12. P Vandepapelière GK Lau G Leroux-Roels 2007 Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine Vaccine 25 8585 8597 10.1016/j.vaccine.2007.09. 072 (Pubitemid 350192039)
13. RP Perrillo CR Campbell GE Sanders FG Regenstein CJ Bodicky 1984 Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis Ann Intern Med 100 43 46
14. JL Dienstag ER Schiff TL Wright 1999 Lamivudine as initial treatment for chronic B in the United States N Engl J Med 341 1256 1263 10.1056/ NEJM199910213411702 (Pubitemid 29489740)
15. RN Chien YF Liaw M Atkins The Asian Hepatitis Lamivudine Trial Group 1999 Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B Hepatology 30 770 774 10.1002/hep.510300313 (Pubitemid 29409422)
16. MR Brunetto F Oliveri G Rocca 1989 Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen Hepatology 10 198 202 10.1002/hep.1840100213